The tumorigenesis of hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC)
has been widely studied. HBV envelope proteins are important for the structure and life cycle …

Hepatitis B virus (HBV) is a global health problem that can lead to cirrhosis and
hepatocellular carcinoma (HCC). Although HBV vaccination has reduced the prevalence Of …

Hepatitis B virus (HBV) is an enveloped partial double-stranded DNA virus that can cause
acute and chronic hepatitis. According to the World Health Organization (WHO) and the …

Background & Aims The hepatitis B virus (HBV) genome encodes specific sequence
elements which promote splicing of viral DNA. It has been previously suggested that spliced …

INTRODUCTION Chronic hepatitis B infection is a global health problem affecting more than
350 million people worldwide. 1 Prolonged liver inflammation caused by active infection with …

Objective Hepatitis B e antigen (HBeAg) seroconversion and hepatitis B surface antigen
(HBsAg) loss are important clinical outcomes for patients with chronic hepatitis B (CHB) …

Background An accurate, single‐point differential diagnosis between HBeAg‐negative
infection (ENI) and chronic hepatitis B (CHB) is an unmet need. Aims To assess the …

Challenges in the management of chronic hepatitis B virus (HBV) infection involve the
prediction of the natural course to identify patients who require antiviral therapy and the …

Background: Accurate, rapid, and cost-effective screening tests for hepatitis B virus (HBV)
and hepatitis C virus (HCV) infection may be useful in laboratories that cannot afford …

Chronic hepatitis B virus (HBV) infection can result in liver cirrhosis, hepatic
decompensation, and hepatocellular carcinoma (HCC). However, the natural course of the …